Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T19:46:57.338Z.
Calculation as of: 2026-10-06T19:46:57.338Z.
Quote observation: 2026-10-06T19:45:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6caa0376099c5ebdf209f9b018955c4d65987c3db8176dc1b5ff0a1c5aca19bf
EARNINGS YIELD
N/A
Bright Minds Biosciences Inc.
Market Cap
$474.58M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$477.04M
Earnings Yield
N/A
TTM Avg
6.10%
3Y Avg
6.10%
5Y Avg
6.10%
Market Cap
$484.31M
Earnings Yield
5.43%
TTM Avg
9.76%
3Y Avg
11.41%
5Y Avg
9.78%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bright Minds Biosciences Inc. (DRUG) | $474.58M | N/A | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $477.04M | N/A | 6.10% | 6.10% | 6.10% |
| Arvinas, Inc. (ARVN)vs › | $471.33M | 2.19% | 1.86% | 1.86% | 1.86% |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | N/A | 0.09% | 0.09% | 0.09% |
| Kamada Ltd. (KMDA)vs › | $468.77M | 4.66% | 4.62% | 4.09% | 3.81% |
| Cerus Corporation (CERS)vs › | $468.55M | N/A | 5.12% | 5.12% | 5.12% |
| Sight Sciences, Inc. (SGHT)vs › | $466.84M | N/A | N/A | N/A | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $484.31M | 5.43% | 9.76% | 11.41% | 9.78% |
| Evolus, Inc. (EOLS)vs › | $486.34M | N/A | N/A | N/A | N/A |
| Oculis Holding AG (OCS)vs › | $491.66M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
